BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7777474)

  • 1. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
    Jakić-Razumović J; Petrovecki M; Dominis M
    Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
    Iyer VK; Raina V; Dawar R
    Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
    Jakić-Razumović J; Labar B; Cör A; Radman I
    Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
    Gan X
    Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
    Crocker J; Macartney JC; Smith PJ
    J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in lymphomas: a quantitative study.
    Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
    Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
    Shimizu K; Izumi R; Ii T; Muraoka K; Inoue T; Fukushima W; Sakamoto K; Tani T; Hashimoto T; Yagi M
    Hepatology; 1995 Feb; 21(2):393-7. PubMed ID: 7843711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.
    Crocker J; Egan MJ
    J Pathol; 1988 Nov; 156(3):233-9. PubMed ID: 3060577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
    Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas.
    Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A
    Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
    Nizze H; Bühring U
    Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
    Glińska H; Papla B; Siuda M; Zulichowska J
    Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.
    Jakić-Razumović J; Tentor D; Petrovecki M; Radman I
    J Clin Pathol; 1993 Oct; 46(10):943-7. PubMed ID: 8227414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.